Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Exp Neurol ; 314: 111-125, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30703361

RESUMO

Retinoid X receptors (RXRs) play an important role in transcription, are involved in numerous cellular networks from cell proliferation to lipid metabolism and are essential for normal eye development. RXRs form homo or heterodimers with other nuclear receptors, bind to DNA response elements and regulate several biological processes including neurogenesis. Mounting evidence suggests that RXR activation by selective RXR modulators (sRXRms) may be neuroprotective in the central nervous system. However, their potential neuroprotective role in the retina and specifically in glaucoma remains unexplored. This study investigated changes in RXR expression in the human and mouse retina under glaucomatous stress conditions and investigated the effect of RXR modulation on the RGCs using pharmacological approaches. RXR protein levels in retina were downregulated in both human glaucoma and experimental RGC injury models while RXR agonist, bexarotene treatment resulted in upregulation of RXR expression particularly in the inner retinal layers. Retinal electrophysiological recordings and histological analysis indicated that inner retinal function and retinal laminar structure were preserved upon treatment with bexarotene. These protective effects were associated with downregulation of ER stress marker response upon bexarotene treatment under glaucoma conditions. Overall, retinal RXR modulation by bexarotene significantly protected RGCs in vivo in both acute and chronic glaucoma models.


Assuntos
Bexaroteno/farmacologia , Bexaroteno/uso terapêutico , Estresse do Retículo Endoplasmático/efeitos dos fármacos , Glaucoma/prevenção & controle , Fármacos Neuroprotetores/farmacologia , Fármacos Neuroprotetores/uso terapêutico , Receptores X de Retinoides/agonistas , Idoso , Idoso de 80 Anos ou mais , Envelhecimento , Animais , Eletrorretinografia , Feminino , Expressão Gênica/efeitos dos fármacos , Glaucoma/patologia , Inibidores de Histona Desacetilases/uso terapêutico , Histona Desacetilases/metabolismo , Humanos , Técnicas In Vitro , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Fenótipo , Retina/efeitos dos fármacos , Retina/metabolismo , Retina/patologia , Receptores X de Retinoides/biossíntese
2.
Biomed Pharmacother ; 96: 1016-1021, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29221723

RESUMO

INTRODUCTION: Thyroid hormone is known to play important role during embryo implantation, however mechanisms underlying its actions in uterus during peri-implantation period has not been fully identified. In this study, we hypothesized that thyroid hormone could affect expression of proteins related to its function, where these could explain mechanisms for its action in uterus during this period. METHODS: Female rats, once rendered hypothyroid via oral administration of methimazole (0.03% in drinking water) for twenty-one days were mated with fertile euthyroid male rats at 1:1 ratio. Pregnancy was confirmed by the presence of vaginal plug and this was designated as day-1. Thyroxine (20, 40 and 80 µg/kg/day) was then subcutaneously administered to pregnant, hypothyroid female rats for three days. A day after last injection (day four pregnancy), female rats were sacrificed and expression of thyroid hormone receptors (TR-α and ß), retinoid X receptor (RXR) and extracellular signal-regulated kinase (ERK1/2) in uterus were quantified by Western blotting while their distribution in endometrium was visualized by immunofluorescence. RESULTS: Expression of TRα-1, TRß-1 and ERK1/2 proteins in uterus increased with increasing doses of thyroxine however no changes in RXR expression was observed. These proteins were found in the stroma with their distribution levels were relatively higher following thyroxine treatment. CONCLUSIONS: Increased expression of TRα-1, TRß-1 and ERK1/2 at day 4 pregnancy in thyroxine-treated hypothyroid pregnant rats indicate the importance of thyroxine in up-regulating expression of these proteins that could help mediate the uterine changes prior to embryo implantation.


Assuntos
Sistema de Sinalização das MAP Quinases/fisiologia , Receptores X de Retinoides/biossíntese , Receptores alfa dos Hormônios Tireóideos/biossíntese , Receptores beta dos Hormônios Tireóideos/biossíntese , Tiroxina/administração & dosagem , Útero/metabolismo , Animais , Blastocisto/efeitos dos fármacos , Blastocisto/metabolismo , Feminino , Expressão Gênica , Hipotireoidismo/tratamento farmacológico , Hipotireoidismo/genética , Hipotireoidismo/metabolismo , Injeções Subcutâneas , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Masculino , Gravidez , Ratos , Ratos Sprague-Dawley , Receptores X de Retinoides/genética , Receptores alfa dos Hormônios Tireóideos/genética , Receptores beta dos Hormônios Tireóideos/genética , Hormônios Tireóideos/fisiologia , Útero/efeitos dos fármacos
3.
J Neurochem ; 142(1): 89-102, 2017 07.
Artigo em Inglês | MEDLINE | ID: mdl-28419454

RESUMO

Despite the recent identification of over 40 missense heterozygous Reelin gene (RELN) mutations in autism spectrum disorder (ASD), none of these has been functionally characterized. Reelin is an integral signaling ligand for proper brain development and post-natal synapse function - properties likely disrupted in ASD patients. We find that the R2290C mutation, which arose de novo in an affected ASD proband, and other analogous mutations in arginine-amino acid-arginine domains reduce protein secretion. Closer analysis of RELN R2290C heterozygous neurospheres reveals up-regulation of Protein Disulfide Isomerase A1, best known as an endoplasmic reticulum-chaperone protein, which has been linked to neuronal pathology. This effect is recapitulated in a heterozygous RELN mouse mutant that is characterized by defective Reelin secretion. These findings suggest that both a deficiency in Reelin signaling and pathologic impairment of Reelin secretion may contribute to ASD risk.


Assuntos
Transtorno do Espectro Autista/genética , Moléculas de Adesão Celular Neuronais/genética , Moléculas de Adesão Celular Neuronais/metabolismo , Proteínas da Matriz Extracelular/genética , Proteínas da Matriz Extracelular/metabolismo , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Isomerases de Dissulfetos de Proteínas/genética , Serina Endopeptidases/genética , Serina Endopeptidases/metabolismo , Animais , Transtorno do Espectro Autista/metabolismo , Diferenciação Celular/genética , Cerebelo/metabolismo , Regulação Enzimológica da Expressão Gênica/genética , Humanos , Camundongos , Camundongos Endogâmicos C57BL , Mutação/genética , Isomerases de Dissulfetos de Proteínas/biossíntese , Edição de RNA , Proteína Reelina , Receptores X de Retinoides/biossíntese , Receptores X de Retinoides/genética
4.
Cancer Res ; 76(18): 5423-30, 2016 09 15.
Artigo em Inglês | MEDLINE | ID: mdl-27530324

RESUMO

Experimental evidence supports a protective role of 25-hydroxyvitamin D [25(OH)D] in breast carcinogenesis, but epidemiologic evidence is inconsistent. Whether plasma 25(OH)D interacts with breast tumor expression of vitamin D receptor (VDR) and retinoid X receptor-α (RXR) has not been investigated. We conducted a nested case-control study in the Nurses' Health Study, with 1,506 invasive breast cancer cases diagnosed after blood donation in 1989-1990, 417 of whom donated a second sample in 2000-2002. VDR and RXR expression were assessed by immunohistochemical staining of tumor microarrays (n = 669 cases). Multivariate relative risks (RR) and 95% confidence intervals (CI) were calculated using conditional logistic regression. Plasma 25(OH)D levels were not associated with breast cancer risk overall [top (≥32.7 ng/mL) vs. bottom (<17.2 ng/mL) quintile RR = 0.87; 95% CI, 0.67-1.13; P trend = 0.21]. 25(OH)D measured in summer (May-October) was significantly inversely associated with risk (top vs. bottom quintile RR = 0.66; 95% CI, 0.46-0.94; P trend = 0.01); winter levels (November-April) were not (RR = 1.10; 95% CI, 0.75-1.60; P trend = 0.64; P interaction = 0.03). 25(OH)D levels were inversely associated with risk of tumors with high expression of stromal nuclear VDR [≥30 ng/mL vs. <30 ng/mL RR (95% CI): VDR ≥ median = 0.67 (0.48-0.93); VDR < median = 0.98 (0.72-1.35), P heterogeneity = 0.12] and significantly stronger for summer measures (P heterogeneity = 0.01). Associations were not significantly different by RXR expression. No overall association was observed between plasma 25(OH)D and breast cancer risk. However, our results suggest women with high, compared with low, plasma 25(OH)D levels in the summer have a reduced breast cancer risk, and plasma 25(OH)D may be inversely associated with risk of tumors expressing high levels of VDR. Cancer Res; 76(18); 5423-30. ©2016 AACR.


Assuntos
Neoplasias da Mama/sangue , Vitamina D/análogos & derivados , Adulto , Idoso , Estudos de Casos e Controles , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Modelos Logísticos , Pessoa de Meia-Idade , Análise de Sequência com Séries de Oligonucleotídeos , Estudos Prospectivos , Radioimunoensaio , Receptores de Calcitriol/biossíntese , Receptores X de Retinoides/biossíntese , Fatores de Risco , Análise Serial de Tecidos , Vitamina D/sangue
5.
J Chem Neuroanat ; 77: 80-92, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27242163

RESUMO

Retinoic acid (RA) is important during development, in neuronal plasticity, and also in peripheral nervous system regeneration. Here we use the frog visual system as a model to investigate the changes in RA signaling that take place after axonal injury to the central nervous system. Immunocytochemistry was used to localize different components of RA signaling within sections of the retina and optic tectum, namely, the synthetic enzyme retinaldehyde dehydrogenase (RALDH), the RA binding proteins CRABPI and II, the retinoic acid receptors RARα, ß and γ, and finally the catabolic enzyme CYP26A1. The levels of these proteins were quantified in extracts of retina and tectum using Western blotting. Animals were studied at 1 week, 3 weeks and 6 weeks after optic nerve transection. At the latter time point the RGC axons were re-entering the optic tectum. All the components of RA signaling were present at low to moderate levels in retinas and tecta of control, unoperated animals. In retina, soon after optic nerve injury there was a large increase in RALDH, some increase in the CRABPs, and a large increase in RGC RARß and (expression. These increases continued as the RGC axons were regenerating, with the addition of later RARα expression at 6 weeks. At no stage did CYP26A1 expression significantly change. In the tectum the levels of RALDH increased after axotomy and during regrowth of axons (3 weeks), then decreased at 6 weeks, at which time the levels of CYP26A1 increased. Axotomy did not cause an immediate increase in tectal RAR levels but RARα and RARß increased after 3 weeks and RARγ only after 6 weeks. These results are consistent with RA signaling playing an important role in the survival and regeneration of frog RGCs.


Assuntos
Traumatismos do Nervo Óptico/fisiopatologia , Transdução de Sinais , Tretinoína/metabolismo , Vias Visuais/fisiopatologia , Animais , Feminino , Regulação da Expressão Gênica , Imuno-Histoquímica , Masculino , Rana pipiens , Receptores do Ácido Retinoico/biossíntese , Retina/fisiopatologia , Retinal Desidrogenase/biossíntese , Células Ganglionares da Retina/metabolismo , Ácido Retinoico 4 Hidroxilase/biossíntese , Ácido Retinoico 4 Hidroxilase/genética , Receptores X de Retinoides/biossíntese , Colículos Superiores/fisiopatologia
6.
Pancreas ; 44(7): 1134-40, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26355550

RESUMO

OBJECTIVES: Pregnane X receptor (PXR) has been involved in human malignancy, either by directly affecting carcinogenesis or by inducing drug-drug interactions and chemotherapy resistance. The present study aimed to assess the clinical significance of PXR in pancreatic adenocarcinoma. METHODS: Pregnane X receptor and its heterodimers' PXR/retinoid X receptor α (RXR-α), RXR-ß, and RXR-γ expression were assessed immunohistochemically on tumoral samples from 55 pancreatic adenocarcinoma patients and were associated with clinicopathologic parameters, tumor proliferative capacity, and patients' survival. RESULTS: Enhanced PXR expression was noted in 24 (43.6%) of 55 pancreatic adenocarcinoma cases. Pancreatic adenocarcinoma patients presenting increased histological grade of tumor differentiation showed a significant increased incidence of elevated PXR expression (P = 0.023). Enhanced PXR/RXR-ß expression was significantly associated with smaller tumor size and earlier clinical stage (P = 0.005 and P = 0.003, respectively). Elevated PXR/RXR-γ expression was significantly associated with smaller tumor size and earlier clinical stage (P = 0.012 and P = 0.014, respectively) and borderline with the absence of lymph node metastases (P = 0.056). In addition, pancreatic adenocarcinoma patients presenting enhanced PXR/RXR-γ expression showed marginally longer survival times compared with those with decreased expression (log-rank test, P = 0.053). CONCLUSIONS: This study supported evidence that PXR and its copartners' overexpression may be associated with favorable clinicopathologic parameters and better outcome in pancreatic adenocarcinoma.


Assuntos
Adenocarcinoma/metabolismo , Neoplasias Pancreáticas/metabolismo , Receptores de Esteroides/biossíntese , Receptores X de Retinoides/biossíntese , Adenocarcinoma/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Distribuição de Qui-Quadrado , Progressão da Doença , Feminino , Humanos , Imuno-Histoquímica/estatística & dados numéricos , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Estadiamento de Neoplasias , Neoplasias Pancreáticas/patologia , Receptor de Pregnano X , Modelos de Riscos Proporcionais , Receptor X Retinoide alfa/biossíntese , Receptor X Retinoide beta/biossíntese , Receptor X Retinoide gama/biossíntese , Neoplasias Pancreáticas
7.
FEBS J ; 281(21): 4815-29, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25161098

RESUMO

Human SPLUNC1 can suppress nasopharyngeal carcinoma (NPC) tumor formation; however, the correlation between SPLUNC1expression and NPC patient prognosis has not been reported. In the present study, we used a large-scale sample of 1015 tissue cores to detect SPLUNC1 expression and its association with patient prognosis. SPLUNC1 expression was reduced in NPC samples compared to nontumor nasopharyngeal epithelium tissues. Positive expression of SPLUNC1 in NPC predicted a better prognosis (disease-free survival, P = 0.034; overall survival, P = 0.048). Cox's proportional hazards model revealed that SPLUNC1 could be a significant prognostic factor affecting disease-free survival (P = 0.027). A cDNA micro-array analyzed by significant analysis of micro-array (SAM) and ingenuity pathway analysis (IPA) revealed that an indirect interaction existed between SPLUNC1 and retinoic acid (RA) in the cancer regulatory network. To further investigate the molecular mechanisms involved, we utilized several bioinformatics tools and identified 12 retinoid X receptors heterodimer binding sites in the promoter region of the SPLUNC1 gene. The transcriptional activity of the SPLUNC1 promoter was up-regulated significantly by all-trans-retinoic acid (ATRA). SPLUNC1 and retinoic acid receptor expression were induced significantly by ATRA, and removal of ATRA led to a progressive loss of SPLUNC1 and retinoic acid receptor expression. ATRA inhibited proliferation and induced the differentiation of NPC cells. Interestingly, over-expression of SPLUNC1 sensitized NPC cells to ATRA, whereas knockdown of SPLUNC1 in HNE1 cells increased cell viability. Under SPLUNC1 knockdown conditions, differentiation was reversed by ATRA treatment. We concluded that SPLUNC1 could potentially predict prognosis for NPC patients and play an important role in ATRA-induced growth inhibition and differentiation in NPC cells.


Assuntos
Carcinoma/metabolismo , Glicoproteínas/fisiologia , Neoplasias Nasofaríngeas/metabolismo , Proteínas de Neoplasias/fisiologia , Fosfoproteínas/fisiologia , Tretinoína/farmacologia , Regiões 5' não Traduzidas/genética , Adolescente , Adulto , Idoso , Sítios de Ligação , Carcinoma/tratamento farmacológico , Carcinoma/mortalidade , Carcinoma/patologia , Ciclo Celular/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , Feminino , Regulação Neoplásica da Expressão Gênica , Glicoproteínas/biossíntese , Glicoproteínas/genética , Humanos , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Neoplasias Nasofaríngeas/tratamento farmacológico , Neoplasias Nasofaríngeas/mortalidade , Neoplasias Nasofaríngeas/patologia , Proteínas de Neoplasias/biossíntese , Proteínas de Neoplasias/genética , Fosfoproteínas/biossíntese , Fosfoproteínas/genética , Prognóstico , Regiões Promotoras Genéticas/efeitos dos fármacos , Regiões Promotoras Genéticas/genética , Interferência de RNA , RNA Interferente Pequeno/farmacologia , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Receptores X de Retinoides/biossíntese , Receptores X de Retinoides/genética , Receptores X de Retinoides/fisiologia , Adulto Jovem
8.
Biomed Res Int ; 2014: 853086, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25013807

RESUMO

(-)-Epigallocatechin-3-gallate (EGCG) and chemotherapeutic agents cotreatment can improve cytotoxicity against cancer cells. We showed that EGCG and the rexinoid 6-OH-11-O-hydroxyphenanthrene (IIF), given together, were cytotoxic toward MCF-7, MCF-7TAM, and MDA-MB-231, three breast carcinoma cell lines showing different molecular characteristics. Cell growth arrest and apoptosis were greater after EGCG and IIF cotreatment than after individual administration. Cytotoxicity was related to upregulation of 67-kDa laminin receptor (LR67), one of the principal molecular targets of EGCG, and activation of the nuclear retinoic X receptors (RXRs) pathway. Furthermore, the transcription factor Forkhead box O3 (Foxo3a), a protein able to trigger apoptosis through upregulation of genes necessary for cell death, was activated. EGCG and IIF cotreatment produced a significant nuclear import of Foxo3a from the cytoplasm in MCF-7, MCF-7TAM, and MDA-MB-231 cells. In MCF-7TAM cells only, Foxo3a nuclear localization was associated with p473AKT downregulation. For the first time we showed that when EGCG and IIF, two harmless molecules, were given together, they might increase cytotoxicity in three breast carcinoma cell lines, two of them being representative of poorly responsive breast carcinoma types.


Assuntos
Neoplasias da Mama/tratamento farmacológico , Catequina/análogos & derivados , Fenantrenos/administração & dosagem , Receptores X de Retinoides/biossíntese , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Apoptose/efeitos dos fármacos , Neoplasias da Mama/genética , Neoplasias da Mama/patologia , Catequina/administração & dosagem , Proliferação de Células/efeitos dos fármacos , Feminino , Proteína Forkhead Box O3 , Fatores de Transcrição Forkhead/biossíntese , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Ligantes , Células MCF-7 , Receptores X de Retinoides/genética
9.
J Steroid Biochem Mol Biol ; 140: 34-43, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24291400

RESUMO

Retinoic acid (RA), the main active metabolite of vitamin A, regulates vertebrate morphogenesis through signaling pathways not yet fully understood. Such process involves the specific activation of retinoic acid and retinoid X receptors (RARs and RXRs), which are nuclear receptors of the steroid/thyroid hormone receptor superfamily. Teleost fish are suitable models to study vertebrate development, such as skeletogenesis. Cell systems capable of in vitro mineralization have been developed for several fish species and may provide new insights into the specific cellular and molecular events related to vitamin A activity in bone, complementary to in vivo studies. This work aims at investigating the in vitro effects of RA (0.5 and 12.5 µM) on proliferation, differentiation and extracellular matrix (ECM) mineralization of two gilthead seabream bone-derived cell lines (VSa13 and VSa16), and at identifying molecular targets of its action through gene expression analysis. RA induced phenotypic changes and cellular proliferation was inhibited in both cell lines in a cell type-dependent manner (36-59% in VSa13 and 17-46% in VSa16 cells). While RA stimulated mineral deposition in VSa13 cell cultures (50-62% stimulation), it inhibited the mineralization of extracellular matrix in VSa16 cells (11-57% inhibition). Expression of hormone receptor genes (rars and rxrs), and extracellular matrix-related genes such as matrix and bone Gla proteins (mgp and bglap), osteopontin (spp1) and type I collagen (col1a1) were differentially regulated upon exposure to RA in proliferating, differentiating and mineralizing cultures of VSa13 and VSa16 cells. Altogether, our results show: (i) RA affects proliferative and mineralogenic activities in two fish skeletal cell types and (ii) that during phenotype transitions, specific RA nuclear receptors and bone-related genes are differentially expressed in a cell type-dependent manner.


Assuntos
Osso e Ossos/metabolismo , Calcificação Fisiológica/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Matriz Extracelular/metabolismo , Tretinoína/farmacologia , Animais , Proteínas de Ligação ao Cálcio/biossíntese , Linhagem Celular , Proteínas da Matriz Extracelular/biossíntese , Expressão Gênica/efeitos dos fármacos , Osteocalcina/biossíntese , Receptores do Ácido Retinoico/biossíntese , Receptores X de Retinoides/biossíntese , Dourada , Proteína de Matriz Gla
10.
Tumour Biol ; 34(4): 2409-18, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23605322

RESUMO

In order to investigate the inhibitory effects and mechanisms of troglitazone (TGZ), a peroxisome proliferator-activated receptor γ (PPARγ) agonist, and retinoid X receptor (RXR) agonist (9-cis-retinoic acid (RA)) on gastric carcinoma cells SGC7901, SGC7901 cells were treated with TGZ and 9-cis-RA, respectively, or in combination. Then, the cell growth, apoptosis, morphological changes, and the expression of PPARγ, RXRγ, Bcl-2, and Bax were detected by MTT assay, flow cytometry, HE staining, immunocytochemistry staining, and Western blot assay, respectively. Our results showed that the growth of SGC7901 cells was inhibited and the cells got sparser at the concentrations of 50 µmol/L TGZ, 20 µmol/L 9-cis-RA, or combination of TGZ (25 µmol/L) and 9-cis-RA (10 µmol/L). Immunocytochemistry and Western blot showed that after 72 h, the expression of PPARγ, RXRγ, and Bax were upregulated; Bcl-2 was downregulated compared with the negative control group. These data indicated that PPARγ agonist and RXR agonist could inhibit the proliferation of SGC7901 cells via inducing the apoptosis, which involved the increase in the level of Bax/Bcl-2. The combination of RXR agonist and PPARγ agonist could induce the maximal inhibitory effects on tumor growth and apoptosis via promoting the formation of RXR/PPARγ heterodimer.


Assuntos
Cromanos/farmacologia , PPAR gama/agonistas , Receptores X de Retinoides/agonistas , Neoplasias Gástricas/tratamento farmacológico , Tiazolidinedionas/farmacologia , Tretinoína/farmacologia , Alitretinoína , Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Regulação para Baixo , Humanos , Hipoglicemiantes/farmacologia , Substâncias Intercalantes/farmacologia , PPAR gama/biossíntese , Propídio/farmacologia , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Receptores X de Retinoides/biossíntese , Troglitazona , Regulação para Cima , Proteína X Associada a bcl-2/biossíntese
11.
Molecules ; 17(9): 10994-1009, 2012 Sep 12.
Artigo em Inglês | MEDLINE | ID: mdl-22971584

RESUMO

The specific aims of this study were to evaluate the inhibition effect on CYP3A of di-n-butyl-di-(4-chlorobenzohydroxamato)tin (IV) (DBDCT), a tin-based complex with high antitumor activity, and the probable mechanism(s) of this action. Adult male SD rats were treated separately with natural saline (NS), lipopolysaccharide (LPS, 5 mg/kg), DBDCT (1.25, 2.5 and 5.0 mg/kg) intraperitoneally for 2 days after induction of CYP3A with dexamethasone (DEX, 100 mg/kg) for 4 days. Western blot analysis and fluorescent quantitation PCR (FQ-PCR) were conducted to determine the changes in expression of CYP3A, PXR, CAR and RXR. The biological accumulation of DBDCT and total Sn were determined by high-performance liquid chromatography (HPLC) and atomic fluorescence spectrometry (AFS). CYP450 content and CYP3A activities were significantly inhibited (p < 0.05) in DBDCT-treated rats compared with the control group, as was the expression of CYP3A (p < 0.05) at both protein and mRNA levels. In DBDCT-treated groups, the expression of PXR protein and mRNA increased, while the expression of CAR decreased. The biological accumulation of DBDCT and Sn in rat livers treated with DBDCT was high. The accumulation of DBDCT and Sn due to the inhibition of CYP3A may be involved in the mechanism of toxicity of DBDCT in rat liver.


Assuntos
Inibidores do Citocromo P-450 CYP3A , Fígado/efeitos dos fármacos , Compostos Orgânicos de Estanho/metabolismo , Compostos Orgânicos de Estanho/farmacologia , Estanho/metabolismo , Animais , Antineoplásicos/química , Antineoplásicos/farmacologia , Antineoplásicos/toxicidade , Citocromo P-450 CYP3A/genética , Citocromo P-450 CYP3A/metabolismo , Dexametasona/farmacologia , Lipopolissacarídeos/farmacologia , Fígado/enzimologia , Masculino , Microssomos Hepáticos/metabolismo , Compostos Orgânicos de Estanho/farmacocinética , Compostos Orgânicos de Estanho/toxicidade , Receptor de Pregnano X , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Receptores de Esteroides/biossíntese , Receptores de Esteroides/genética , Receptores X de Retinoides/biossíntese , Receptores X de Retinoides/genética
12.
Alcohol Clin Exp Res ; 35(9): 1584-92, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21599713

RESUMO

BACKGROUND: Bioinformatic resources suggest that adipose tissue expresses mRNAs for alcohol dehydrogenases (ADHs) and ALDH2, and epidemiological studies indicate that heavy alcohol use reduces adipose tissue mass. We therefore characterized the expression of alcohol metabolizing enzymes in human, rat and mouse adipose tissue, preadipocytes, and adipocytes, the ability of adipocytes to metabolize ethanol, and the effects of ethanol on differentiation of human adipose stromal cells (hASCs). METHODS: Adipose tissue, preadipocytes, and adipocytes were collected from rodents or from humans undergoing bariatric surgery. hASCs were differentiated in vitro using standard methods. Gene expression and cellular differentiation were analyzed by Western blotting, RT-PCR, and microscopy. RESULTS: Class I ADH was expressed in human > mouse > rat adipose tissue, whereas ALDH2 was high in all samples. ADH, catalase, and ALDH2 were induced during differentiation of hASCs. The presence of 50 mM ethanol markedly reduced the differentiation of hASCs; this effect was associated with inhibition of expression of transcription factors required for differentiation, but did not depend on the ability of the cells to metabolize ethanol. CONCLUSIONS: Human adipose tissue expresses alcohol oxidizing enzymes. The presence of ethanol at physiologically relevant concentrations inhibits differentiation of hASCs. Ethanol could alter adipose tissue biology, inducing a form of acquired lipodystrophy, which is consistent with epidemiological studies.


Assuntos
Adipócitos/efeitos dos fármacos , Adipócitos/metabolismo , Tecido Adiposo/metabolismo , Álcool Desidrogenase/biossíntese , Etanol/metabolismo , Etanol/toxicidade , Células Estromais/efeitos dos fármacos , Células Estromais/metabolismo , Acetil-CoA Carboxilase/biossíntese , Actinas/metabolismo , Adipócitos/citologia , Adipócitos/enzimologia , Tecido Adiposo/citologia , Tecido Adiposo/enzimologia , Animais , Diferenciação Celular , Células Cultivadas , Depressores do Sistema Nervoso Central/metabolismo , Depressores do Sistema Nervoso Central/toxicidade , Citocromo P-450 CYP2E1/biossíntese , Feminino , Expressão Gênica , Humanos , Masculino , Camundongos , PPAR gama/biossíntese , Ratos , Receptores X de Retinoides/biossíntese , Proteína de Ligação a Elemento Regulador de Esterol 1/biossíntese , Células Estromais/citologia , Células Estromais/enzimologia , Fatores de Transcrição/metabolismo , Células Tumorais Cultivadas
13.
Mol Hum Reprod ; 17(10): 653-60, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21511721

RESUMO

Prostaglandins participate in a variety of female reproductive processes, including ovulation, fertilization, embryo implantation and parturition. In particular, maternal prostacyclin (PGI(2)) is critical for embryo implantation and the action of PGI(2) is not mediated via its G-protein-coupled membrane receptor, IP, but its nuclear receptor, peroxisome-proliferator-activated receptor δ (PPARδ). Recently, several studies have shown that PGI(2) enhances blastocyst development and/or hatching rate in vitro, and subsequently implantation and live birth rates in mice. However, the mechanism by which PGI(2) improves preimplantation embryo development in vitro remains unclear. Using molecular, pharmacologic and genetic approaches, we show that PGI(2)-induced PPARδ activation accelerates blastocyst hatching in mice. mRNAs for PPARδ, retinoid X receptor (heterodimeric partners of PPARδ) and PGI(2) synthase (PGIS) are temporally induced after zygotic gene activation, and their expression reaches maximum levels at the blastocyst stage, suggesting that functional complex of PPARδ can be formed in the blastocyst. Carbaprostacyclin (a stable analogue of PGI(2)) and GW501516 (a PPARδ selective agonist) significantly accelerated blastocyst hatching but did not increase total cell number of cultured blastocysts. Whereas U51605 (a PGIS inhibitor) interfered with blastocyst hatching, GW501516 restored U51605-induced retarded hatching. In contrast to the improvement of blastocyst hatching by PPARδ agonists, PPAR antagonists significantly inhibited blastocyst hatching. Furthermore, deletion of PPARδ at early stages of preimplantation mouse embryos caused delay of blastocyst hatching, but did not impair blastocyst development. Taken together, PGI(2)-induced PPARδ activation accelerates blastocyst hatching in mice.


Assuntos
Blastocisto/fisiologia , Implantação do Embrião , Desenvolvimento Embrionário , PPAR delta/metabolismo , Anilidas/farmacologia , Animais , Benzamidas/farmacologia , Inibidores das Enzimas do Citocromo P-450 , Sistema Enzimático do Citocromo P-450/biossíntese , Sistema Enzimático do Citocromo P-450/genética , Implantação do Embrião/efeitos dos fármacos , Desenvolvimento Embrionário/efeitos dos fármacos , Epoprostenol/análogos & derivados , Epoprostenol/metabolismo , Epoprostenol/farmacologia , Feminino , Oxirredutases Intramoleculares/antagonistas & inibidores , Oxirredutases Intramoleculares/biossíntese , Oxirredutases Intramoleculares/genética , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos ICR , Camundongos Knockout , PPAR delta/antagonistas & inibidores , Gravidez , Prostaglandinas H/farmacologia , Piridinas/farmacologia , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptores X de Retinoides/biossíntese , Receptores X de Retinoides/genética , Tiazóis/farmacologia
14.
Br J Nutr ; 105(6): 895-901, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21114893

RESUMO

Several epidemiological studies have related an increase of lipids in the postprandial state to an individual risk for the development of CVD, possibly due to the increased plasma levels of TAG and fatty acids (FA) through enzymes of FA metabolism. The interaction between nutrition and the human genome determines gene expression and metabolic response. The aim of the present study was to evaluate the influence of a fat overload on the gene mRNA levels of lipogenic regulators in peripheral blood mononuclear cells (PBMC) from patients with the metabolic syndrome. The study included twenty-one patients with criteria for the metabolic syndrome who underwent a fat overload. Measurements were made before and after the fat overload of anthropometric and biochemical variables and also the gene mRNA levels of lipogenic factors. The main results were that the fat overload led to an increased mRNA levels of sterol regulatory element binding protein-1 (SREBP1), retinoid X receptor α (RXRα) and liver X receptor α (LXRα) in PBMC, and this increase was associated with the FA synthase (FASN) mRNA levels. We also found that TAG levels correlated with FASN mRNA levels. In addition, there was a positive correlation of SREBP1 with RXRα and of LXRα with the plasma lipoperoxide concentration. The fat overload led to an increase in regulators of lipogenesis in PBMC from patients with the metabolic syndrome.


Assuntos
Gorduras na Dieta/farmacologia , Ácido Graxo Sintases/metabolismo , Lipogênese/efeitos dos fármacos , Síndrome Metabólica/metabolismo , Receptores Nucleares Órfãos/biossíntese , Receptores X de Retinoides/biossíntese , Proteína de Ligação a Elemento Regulador de Esterol 1/metabolismo , Gorduras na Dieta/administração & dosagem , Ácido Graxo Sintases/genética , Feminino , Humanos , Leucócitos Mononucleares/efeitos dos fármacos , Peróxidos Lipídicos/sangue , Lipogênese/genética , Lipogênese/fisiologia , Receptores X do Fígado , Masculino , Síndrome Metabólica/genética , RNA Mensageiro/biossíntese , Proteína de Ligação a Elemento Regulador de Esterol 1/genética , Triglicerídeos/sangue
15.
Biomed Khim ; 56(4): 480-9, 2010.
Artigo em Russo | MEDLINE | ID: mdl-21032898

RESUMO

Earlier it was shown that male mice of the DD/He strain were highly susceptible to ortho-aminoasotoluene (OAT) induced hepatocarcinogenesis, and resistant to spontaneous liver tumor development as compared to the CC57BR/Mv strain. In the present work we have made a comparative investigation of peroxisome proliferator-activated receptor (PPAR), liver X-receptor (LXR) and retinoic X-receptor (RXR) mRNA levels in liver as well as concentrations of corticosterone, glucose, lipids and insulin in blood of male DD/He and CC57BR/Mv mice. Using the multiplex RT-PCR method it was found that PPAR-alpha, PPAR-gamma, RXR-alpha and RXR-beta mRNA content was essentially decreased in the liver of DD mice as compared to mice of the CC57BR strain. No significant interstrain differences of LXR-alpha and LXR-beta mRNA content were found. In DD micetere was more then the 3-fold decrease of blood content of corticosterone, which is involved in PPAR and RXR regulation. DD mice demonstrated a significant decrease in blood serum glucose and insulin concentrations as well as higher reactivity to insulin as compared with CC57BR mice. Elevated blood total cholesterol and cholesterol HDL level were found in DD mice whereas triglyceride content was basically the same in both mouse strains. It is known that glucocorticoids, PPAR and RXR play crucial role in transcription regulation of inflammation response. Therefore our data allow to suggest that decreased corticosterone level in blood, PPAR and RXR mRNA content in liver of the DD strain may lead to induction of inflammation by OAT exposure, resulting in a high incidence of tumorigenesis in this strain.


Assuntos
Glicemia/metabolismo , Lipídeos/sangue , Neoplasias Hepáticas/metabolismo , Receptores Nucleares Órfãos/biossíntese , Receptores Ativados por Proliferador de Peroxissomo/biossíntese , Receptores X de Retinoides/biossíntese , Animais , Corticosterona/sangue , Suscetibilidade a Doenças , Insulina/sangue , Neoplasias Hepáticas/etiologia , Receptores X do Fígado , Masculino , Camundongos , Camundongos Endogâmicos , Especificidade da Espécie
16.
Comp Biochem Physiol A Mol Integr Physiol ; 157(3): 198-203, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20601055

RESUMO

This study investigated the effects of dietary lutein and polyunsaturated fatty acids (PUFA) on the total lutein and lipid levels, the peroxisome proliferators activated receptors (PPAR) alpha and gamma, retinoic acid X receptor (RXR) alpha and gamma and IL-1 mRNA levels in chicken (Gallus gallus) liver and spleen. In experiment I, chickens were fed either 0, 25 or 50mg lutein in a diet with 3% PUFA fat. In experiment II, chickens were fed either 3 or 6% PUFA fat with 25mg lutein. At 23d of age, chickens were injected with LPS. LPS injection decreased the lutein content and increased the fat content in the liver and spleen in both experiments. Increasing dietary PUFA fat to 6% ameliorated the LPS-induced lutein depletion in experiment II. LPS injection increased IL-1 and decreased splenic PPARalpha, PPARgamma, RXRalpha mRNA in experiment I and II. The LPS-induced PPARalpha and RXRalpha downregulation were partially reversed by increasing the dietary lutein content to 50mg/kg feed in experiment I and by increasing the dietary PUFA fat content to 6% in experiment II. Increasing dietary lutein content to 50mg/kg feed increased PPARgamma mRNA amount only in the LPS untreated groups in experiment I. Increasing dietary PUFA fat or LPS injection in the 6% PUFA fat group upregulated PPARgamma mRNA in experiment II. Increasing dietary PUFA fat to 6% blunted the increase in IL-1 mRNA due to LPS. It is concluded that dietary lutein and PUFA fat were anti-inflammatory due to modification of immune tissue lutein content, PPAR, RXR isomers and IL-1beta mRNA levels in liver and spleen.


Assuntos
Gorduras na Dieta/farmacologia , Ácidos Graxos Insaturados/farmacologia , Inflamação/metabolismo , Luteína/farmacologia , Receptores Ativados por Proliferador de Peroxissomo/biossíntese , Receptores X de Retinoides/biossíntese , Animais , Galinhas , Dieta , Inflamação/induzido quimicamente , Lipopolissacarídeos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Baço/efeitos dos fármacos , Baço/metabolismo
17.
J Clin Endocrinol Metab ; 95(6): 3067-72, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20357174

RESUMO

CONTEXT AND OBJECTIVE: Genistein aglycone positively affects postmenopausal symptoms. However, questions about its long-term safety on the thyroid gland still remain. DESIGN: The parent study was a randomized, double-blind, placebo-controlled trial involving 389 osteopenic, postmenopausal women for 24 months. A subcohort (138 patients) continued therapy for an additional year. SETTING: Patients received ambulatory care. PATIENTS AND INTERVENTIONS: Participants received 54 mg of genistein aglycone daily (n = 71) or placebo (n = 67), plus calcium and vitamin D(3) at therapeutic doses. Circulating thyroid hormones (TSH, free T(3), free T(4)) and autoantibodies (thyroid peroxidase, thyroglobulin, and thyroid microsomal antigen) were assessed in 40 genistein and 37 placebo subjects who completed 3 yr. Thyroid hormone receptor (THRalpha and THRbeta) and retinoid receptor (RARalpha, RARgamma, and RXRalpha) expression from peripheral blood monocytes was also evaluated at baseline, 12, 24, and 36 months in all 3-yr completers. RESULTS: Genistein administration over 3 yr did not affect serum thyroid hormones or autoantibodies. In addition, there were no differences in THRalpha, THRbeta, RARalpha, RARgamma, or RXRalpha mRNA expression between groups. CONCLUSION: These data suggest that genistein aglycone intake does not significantly increase the risk of clinical or subclinical hypothyroidism at the dose of 54 mg/d.


Assuntos
Genisteína/efeitos adversos , Pós-Menopausa/fisiologia , Glândula Tireoide/efeitos dos fármacos , Idoso , Índice de Massa Corporal , Dieta , Método Duplo-Cego , Feminino , Genisteína/sangue , Humanos , Imunoglobulinas Estimuladoras da Glândula Tireoide/sangue , Lipídeos/sangue , Pessoa de Meia-Idade , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Receptores dos Hormônios Tireóideos/biossíntese , Receptores dos Hormônios Tireóideos/metabolismo , Receptores X de Retinoides/biossíntese , Receptores X de Retinoides/metabolismo , Testes de Função Tireóidea , Tireotropina/sangue , Tiroxina/sangue , Tri-Iodotironina/sangue
18.
Mol Pharmacol ; 76(6): 1360-9, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19786558

RESUMO

The basic helix-loop-helix proteins differentiated embryo chondrocyte 1 (DEC1) and DEC2 are involved in circadian rhythm control. Because the metabolism of dietary nutrients has been linked to circadian regulation, we examined the effect of DEC1 and DEC2 on the function of the metabolite-sensing nuclear receptors, ligand-dependent transcription factors, including retinoid X receptor (RXR) and liver X receptor (LXR). Transfection assays showed that DEC1 and DEC2 repressed ligand-dependent transactivation by RXR. Knockdown of endogenous DEC1 and DEC2 expression with small interfering RNAs augmented ligand-dependent RXRalpha transactivation. DEC1 and DEC2 interacted directly with RXRalpha, and ligand addition enhanced their association. DEC1 and DEC2 modified interaction of RXRalpha with cofactor proteins. Transfection assays using DEC1 and DEC2 mutants revealed that the C-terminal region of DEC2 is required for repression and that an LXXLL motif in DEC1 and DEC2 is necessary for RXRalpha repression. DEC1 and DEC2 repressed the induction of LXR target genes, associated with the promoter of an LXR target gene, and dissociated from the promoter with ligand treatment. Knockdown of endogenous DEC1 and DEC2 enhanced the LXR target gene expression in hepatocytes. Expression of Dec1, Dec2, and Srebp-1c showed a circadian rhythm in the liver of mice, whereas that of Lxralpha, Lxrbeta, and Rxralpha was not rhythmic. DEC1 and DEC2 also repressed the transactivation of other RXR heterodimers, such as farnesoid X receptor, vitamin D receptor, and retinoic acid receptor. Thus, the repressor function of DEC1 and DEC2 may be extended to other RXR heterodimer nuclear receptors.


Assuntos
Fatores de Transcrição Hélice-Alça-Hélice Básicos/fisiologia , Condrócitos/fisiologia , Receptores X de Retinoides/fisiologia , Proteínas Supressoras de Tumor/fisiologia , Animais , Linhagem Celular , Regulação para Baixo , Glutationa Transferase/biossíntese , Histona Desacetilases/fisiologia , Proteínas de Homeodomínio/fisiologia , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Receptor X Retinoide alfa/biossíntese , Receptor X Retinoide alfa/fisiologia , Receptores X de Retinoides/biossíntese , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de Transcrição/fisiologia , Ativação Transcricional/fisiologia , Transfecção
19.
Pathol Int ; 59(3): 152-60, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19261092

RESUMO

Liver X receptor (LXR) is a nuclear receptor that acts as a sterol sensor and metabolic regulator of cholesterol and lipid homeostasis. The foam cell transformation of macrophages (Mvarphi) is considered a critical process in atherosclerotic lesions. The relationship, however, of the foam cell transformation of Mvarphi and LXR is not fully understood. The purpose of the present study was to examine the expression of LXRalpha, retinoid X receptor (RXR)alpha, ATP-binding cassette transporter (ABCA1), and macrophage scavenger receptor A (MSR-A), and lipid accumulation in human monocyte-derived Mvarphi. The expression of LXRalpha, ABCA1, MSR-A in 7 day cultured granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced Mvarphi (GM-Mvarphi) was significantly higher than that in 7 day cultured M-CSF-induced Mvarphi (M-Mvarphi). The expression levels of LXRalpha, ABCA1 and MSR-A protein decreased from 48 h to 5 days after the addition of lipopolysaccharide (LPS) in GM-Mvarphi, but only MSR-A protein decreased at 5 days after the addition of LPS in M-Mvarphi. Intracellular lipid accumulation was clearly observed when GM-Mvarphi was pre-stimulated with LPS for 48 h and incubated with oxidized LDL for an additional 5 days. These findings suggest that the inhibitory activity of LXRalpha, ABCA1 and MSR-A by LPS may be related to the transformation of Mvarphis, especially GM-Mvarphi into foam cells.


Assuntos
Proteínas de Ligação a DNA/biossíntese , Células Espumosas/metabolismo , Regulação da Expressão Gênica , Fator Estimulador de Colônias de Granulócitos e Macrófagos/metabolismo , Metabolismo dos Lipídeos/genética , Receptores Citoplasmáticos e Nucleares/biossíntese , Transportador 1 de Cassete de Ligação de ATP , Transportadores de Cassetes de Ligação de ATP/biossíntese , Transportadores de Cassetes de Ligação de ATP/genética , Western Blotting , Proteínas de Ligação a DNA/genética , Células Espumosas/citologia , Expressão Gênica , Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Humanos , Imuno-Histoquímica , Lipopolissacarídeos/farmacologia , Receptores X do Fígado , Receptores Nucleares Órfãos , Receptores Citoplasmáticos e Nucleares/genética , Receptores X de Retinoides/biossíntese , Receptores X de Retinoides/genética , Receptores Depuradores Classe A/biossíntese , Receptores Depuradores Classe A/genética
20.
Eur J Endocrinol ; 160(4): 631-8, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19155317

RESUMO

BACKGROUND: Although differential expression of retinoic acid receptor (RAR) subtypes between benign and malignant thyroid tissues has been described, their diagnostic value has not been reported. AIM: To investigate the diagnostic accuracy of RAR and retinoid X receptor (RXR) subtype protein expression for the differential diagnosis of thyroid neoplasms. METHODS: We used a tissue array containing 93 benign thyroid tissues (normal thyroid, multinodular goiter, and follicular adenoma (FA)) and 77 thyroid carcinomas (papillary thyroid carcinoma (PTC), follicular thyroid carcinoma, and follicular variant of PTC (FVPTC)). Immunostaining was done for RAR and RXR subtypes. Staining was analyzed semiquantitatively based on receiver operating curve analyses and using hierarchical cluster analysis. RESULTS: We found increased expression of cytoplasmic (c) RARA, cRARG, cRXRB and decreased expression of nuclear (n) RARB, nRARG, and nRXRA in thyroid carcinomas compared with benign tissues. We found three proteins differently expressed between FA and FTC and five proteins differentially expressed between FA and FVPTC, with high diagnostic accuracies. Using cluster analysis, the combination of negative staining of membranous RXRB and positive staining for cRXRB had a high positive predictive value (98%) for malignant thyroid disease, whereas the combination of positive nRXRA and negative cRXRB staining had a high predictive value (91%) for benign thyroid lesions. CONCLUSION: We conclude that differences in RAR and RXR subtype protein expression may be valuable for the differential diagnosis of thyroid neoplasms. The results of this study and especially the value of cluster analysis have to be confirmed in subsequent studies.


Assuntos
Receptores do Ácido Retinoico/biossíntese , Receptores do Ácido Retinoico/genética , Receptores X de Retinoides/biossíntese , Receptores X de Retinoides/genética , Neoplasias da Glândula Tireoide/diagnóstico , Neoplasias da Glândula Tireoide/genética , Núcleo Celular/metabolismo , Análise por Conglomerados , Citoplasma/metabolismo , Diagnóstico Diferencial , Intervalo Livre de Doença , Regulação Neoplásica da Expressão Gênica/genética , Humanos , Imuno-Histoquímica , Análise em Microsséries , Recidiva Local de Neoplasia , Curva ROC
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...